IPO Boutique

Treace Medical Concepts, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Treace Medical Concepts, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Treace Medical Concepts, Inc.TMCI -
NASDAQ
$15.00-$17.00 $17.00 $24.5011.25 million4/23/2021
JP Morgan, Morgan Stanley
Co-Manager(s):
SVB Leerink, Stifel
Health Care
Filing(s):

Filed 2021-03-30
Terms Added 2021-04-19



Treace Medical Concepts, Inc. Quote & Chart - Click for current quote - TMCI

About Treace Medical Concepts, Inc. (adapted from Treace Medical Concepts, Inc. prospectus):
They are a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions).

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "TMCI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved